Icahn School of Medicine researchers have reported that they discovered an ingredient in allergy medicine that can reduce lung cancer tumors. In their study, they found that when blocked, an allergy pathway releases anti-tumor immunity against non-small cell lung cancer (NSCLC). The findings were described in issue of Nature and showed one out of six